NEW BRUNSWICK, N.J. - Johnson & Johnson announced on Thursday that preliminary data shows their one-shot COVID-19 vaccine provides "strong" protection against the delta variant, according to a company news release.
In addition, the company stated their vaccine provides a durable immune response for at least eight months against the delta variant, which researchers believe to be more transmissible than previously discovered variants. "Today’s newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. "We believe that our vaccine offers durable.